Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Financials
Fierce Pharma
Narcan maker Emergent axes top R&D post in sweeping restructuring
In a bold move, Emergent will eliminate the role of head of R&D as part of a layoff round across all areas of the company.
Angus Liu
Aug 5, 2026 8:16pm
Fierce Pharma
BMS delays key Cobenfy, milvexian readouts amid Q2 beat
Jul 30, 2026 10:12am
Fierce Pharma
Daiichi Sankyo targets global top 5 oncology rank by 2035
May 11, 2026 10:22am
Fierce Pharma
Sarepta CEO to retire, citing 'shocking and ironic twist of fate'
Feb 26, 2026 11:30am
Fierce Pharma
Astellas lifts forecast as Vyloy surge counters trial miss
Feb 5, 2026 11:00am
Fierce Pharma
Halozyme catches M&A wave to snap up Surf Bio
Jan 28, 2026 2:06pm